Annual Operating Profit
-$349.40 M
+$90.52 M+20.58%
31 December 2023
Summary:
PTC Therapeutics annual operaing income is currently -$349.40 million, with the most recent change of +$90.52 million (+20.58%) on 31 December 2023. During the last 3 years, it has risen by +$48.47 million (+12.18%). PTCT annual operating profit is now -1242.51% below its all-time high of $30.58 million, reached on 31 December 2011.PTCT Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$51.97 M
-$18.61 M-55.79%
30 September 2024
Summary:
PTC Therapeutics quarterly operating income is currently -$51.97 million, with the most recent change of -$18.61 million (-55.79%) on 30 September 2024. Over the past year, it has increased by +$64.70 million (+55.46%). PTCT quarterly operating profit is now -1053.50% below its all-time high of $5.45 million, reached on 31 December 2017.PTCT Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$127.76 M
+$64.70 M+33.62%
30 September 2024
Summary:
PTC Therapeutics TTM operating income is currently -$127.76 million, with the most recent change of +$64.70 million (+33.62%) on 30 September 2024. Over the past year, it has increased by +$385.42 million (+75.10%). PTCT TTM operating profit is now -1953.89% below its all-time high of -$6.22 million, reached on 31 March 2012.PTCT TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTCT Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.6% | +55.5% | +75.1% |
| 3 y3 years | +12.2% | +36.8% | +65.3% |
| 5 y5 years | -262.7% | -1.9% | +19.3% |
PTCT Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +20.6% | -1765.6% | +67.7% | at high | +75.1% |
| 5 y | 5 years | -262.7% | +20.6% | -1765.6% | +69.3% | at high | +75.1% |
| alltime | all time | -1242.5% | +20.6% | -1053.5% | +69.3% | -1953.9% | +75.1% |
PTC Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$51.97 M(+55.8%) | -$127.76 M(-33.6%) |
| June 2024 | - | -$33.36 M(-26.8%) | -$192.45 M(-31.2%) |
| Mar 2024 | - | -$45.55 M(-1560.0%) | -$279.74 M(-19.9%) |
| Dec 2023 | -$349.40 M(-20.6%) | $3.12 M(-102.7%) | -$349.40 M(-31.9%) |
| Sept 2023 | - | -$116.66 M(-3.3%) | -$513.18 M(+9.2%) |
| June 2023 | - | -$120.64 M(+4.7%) | -$470.00 M(+2.9%) |
| Mar 2023 | - | -$115.22 M(-28.3%) | -$456.92 M(+3.9%) |
| Dec 2022 | -$439.93 M(+17.3%) | -$160.66 M(+118.6%) | -$439.93 M(+17.0%) |
| Sept 2022 | - | -$73.49 M(-31.7%) | -$376.10 M(-2.3%) |
| June 2022 | - | -$107.56 M(+9.5%) | -$384.89 M(+2.6%) |
| Mar 2022 | - | -$98.22 M(+1.4%) | -$375.12 M(+0.0%) |
| Dec 2021 | -$374.94 M(-5.8%) | -$96.83 M(+17.7%) | -$374.95 M(+1.8%) |
| Sept 2021 | - | -$82.28 M(-15.9%) | -$368.19 M(+10.7%) |
| June 2021 | - | -$97.79 M(-0.3%) | -$332.65 M(-17.6%) |
| Mar 2021 | - | -$98.05 M(+8.9%) | -$403.83 M(+1.5%) |
| Dec 2020 | -$397.88 M(+106.4%) | -$90.07 M(+92.7%) | -$397.88 M(+8.1%) |
| Sept 2020 | - | -$46.73 M(-72.3%) | -$368.19 M(-1.1%) |
| June 2020 | - | -$168.98 M(+83.5%) | -$372.43 M(+57.2%) |
| Mar 2020 | - | -$92.09 M(+52.5%) | -$236.91 M(+22.9%) |
| Dec 2019 | -$192.80 M(+100.1%) | -$60.38 M(+18.5%) | -$192.80 M(+21.9%) |
| Sept 2019 | - | -$50.98 M(+52.4%) | -$158.21 M(+1.8%) |
| June 2019 | - | -$33.46 M(-30.3%) | -$155.47 M(+21.9%) |
| Mar 2019 | - | -$47.98 M(+86.0%) | -$127.58 M(+32.4%) |
| Dec 2018 | -$96.34 M | -$25.80 M(-46.5%) | -$96.34 M(+48.0%) |
| Sept 2018 | - | -$48.23 M(+765.3%) | -$65.10 M(+36.3%) |
| June 2018 | - | -$5.57 M(-66.7%) | -$47.76 M(-12.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$16.74 M(-407.2%) | -$54.68 M(-15.0%) |
| Dec 2017 | -$64.29 M(-51.3%) | $5.45 M(-117.6%) | -$64.29 M(-32.1%) |
| Sept 2017 | - | -$30.89 M(+147.2%) | -$94.74 M(-1.2%) |
| June 2017 | - | -$12.50 M(-52.6%) | -$95.91 M(-20.1%) |
| Mar 2017 | - | -$26.36 M(+5.5%) | -$119.97 M(-9.2%) |
| Dec 2016 | -$132.06 M(-21.0%) | -$24.99 M(-22.1%) | -$132.06 M(-14.9%) |
| Sept 2016 | - | -$32.06 M(-12.3%) | -$155.27 M(-6.1%) |
| June 2016 | - | -$36.56 M(-4.9%) | -$165.44 M(-1.2%) |
| Mar 2016 | - | -$38.44 M(-20.2%) | -$167.50 M(+0.2%) |
| Dec 2015 | -$167.13 M(+68.1%) | -$48.20 M(+14.1%) | -$167.13 M(+10.6%) |
| Sept 2015 | - | -$42.23 M(+9.3%) | -$151.16 M(+10.7%) |
| June 2015 | - | -$38.63 M(+1.5%) | -$136.53 M(+10.8%) |
| Mar 2015 | - | -$38.07 M(+18.1%) | -$123.27 M(+24.0%) |
| Dec 2014 | -$99.41 M(+119.0%) | -$32.23 M(+16.8%) | -$99.41 M(+16.6%) |
| Sept 2014 | - | -$27.60 M(+8.8%) | -$85.28 M(+37.7%) |
| June 2014 | - | -$25.37 M(+78.5%) | -$61.95 M(+21.4%) |
| Mar 2014 | - | -$14.21 M(-21.5%) | -$51.03 M(+12.4%) |
| Dec 2013 | -$45.40 M(+69.3%) | -$18.09 M(+323.1%) | -$45.40 M(+36.2%) |
| Sept 2013 | - | -$4.28 M(-70.4%) | -$33.34 M(-7.7%) |
| June 2013 | - | -$14.45 M(+68.5%) | -$36.12 M(+23.8%) |
| Mar 2013 | - | -$8.58 M(+42.1%) | -$29.16 M(+8.8%) |
| Dec 2012 | -$26.81 M(-187.7%) | -$6.03 M(-14.5%) | -$26.81 M(+29.0%) |
| Sept 2012 | - | -$7.06 M(-5.9%) | -$20.77 M(+51.4%) |
| June 2012 | - | -$7.50 M(+20.5%) | -$13.72 M(+120.5%) |
| Mar 2012 | - | -$6.22 M | -$6.22 M |
| Dec 2011 | $30.58 M | - | - |
FAQ
- What is PTC Therapeutics annual operaing income?
- What is the all time high annual operating profit for PTC Therapeutics?
- What is PTC Therapeutics annual operating profit year-on-year change?
- What is PTC Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for PTC Therapeutics?
- What is PTC Therapeutics quarterly operating profit year-on-year change?
- What is PTC Therapeutics TTM operating income?
- What is the all time high TTM operating profit for PTC Therapeutics?
- What is PTC Therapeutics TTM operating profit year-on-year change?
What is PTC Therapeutics annual operaing income?
The current annual operating profit of PTCT is -$349.40 M
What is the all time high annual operating profit for PTC Therapeutics?
PTC Therapeutics all-time high annual operaing income is $30.58 M
What is PTC Therapeutics annual operating profit year-on-year change?
Over the past year, PTCT annual operaing income has changed by +$90.52 M (+20.58%)
What is PTC Therapeutics quarterly operating income?
The current quarterly operating profit of PTCT is -$51.97 M
What is the all time high quarterly operating profit for PTC Therapeutics?
PTC Therapeutics all-time high quarterly operating income is $5.45 M
What is PTC Therapeutics quarterly operating profit year-on-year change?
Over the past year, PTCT quarterly operating income has changed by +$64.70 M (+55.46%)
What is PTC Therapeutics TTM operating income?
The current TTM operating profit of PTCT is -$127.76 M
What is the all time high TTM operating profit for PTC Therapeutics?
PTC Therapeutics all-time high TTM operating income is -$6.22 M
What is PTC Therapeutics TTM operating profit year-on-year change?
Over the past year, PTCT TTM operating income has changed by +$385.42 M (+75.10%)